Summary#

The official short title is Frontotemporal Degeneration Awareness Week. This California Senate Concurrent Resolution does not amend an existing Act or create a new operating program; it declares September 28 to October 4, 2026, inclusive, as Frontotemporal Degeneration Awareness Week. Its stated goal is to increase awareness of the disease.

• The Legislature made the awareness-week declaration.
• The Secretary of the Senate must send copies of the resolution to its author for distribution.
• The resolution does not require agencies, health providers, or other groups to hold events or take other awareness steps.
• The resolution was enacted, but the declared week has now passed.

What it means for you#

• People with frontotemporal degeneration (FTD), families, and the public: The resolution names a week for awareness. It does not create a new health service, benefit, right, or protection.
• Secretary of the Senate: Must send copies of the resolution to its author for distribution. The resolution does not specify how many copies or who must receive them.
• Taxpayers: The resolution does not set a tax, fee, fine, or public benefit.

Money#

No cost estimate is provided in the available material; it says the measure had no fiscal committee review.

• The resolution makes no appropriation and sets no funding for events or services.
• It does not state whether any costs would arise from distributing copies or from voluntary awareness activities.

What is unclear#

• The resolution does not say what distribution of copies entails or who should receive them.
• It does not assign any agency or group responsibility for public awareness activities beyond the Secretary of the Senate’s duty to send copies to the author.
• It does not provide funding, deadlines for distribution, or reporting requirements.

Case for#

• A possible argument for the resolution is that naming an awareness week gives public attention to a serious condition, as the resolution’s stated goal.
• The resolution cites challenges including delayed diagnosis and effects on speech, behavior, and movement. Recognizing the week may help bring those concerns to public attention.
• The measure is limited to a declaration and copy distribution; it does not impose new requirements on patients, providers, or businesses.

Case against#

• One concern is that the resolution does not require concrete awareness activities or fund them, so its practical effect may be limited to the declaration and copy distribution.
• It does not set goals for measuring whether awareness increased or whether people affected by FTD gained access to additional support.
• The resolution gives no details about who will carry out further awareness work or pay for it.